Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Felix Alt

Corrigendum to “IQP-VV-102, a Novel Proprietary Composition for Weight Reduction: A Double-Blind Randomized Clinical Trial for Evaluation of Efficacy and Safety”

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2016English

Related publications

Efficacy and Safety of Baclofen for Alcohol Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial

Alcoholism: Clinical and Experimental Research
MedicinePsychiatryMental HealthToxicology
2010English

Corrigendum to “Efficacy and Safety of Sipjeondaebo-Tang for Anorexia in Patients With Cancer: A Pilot, Randomized, Double-Blind, Placebo-Controlled Trial”

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2018English

Lidocaine for Systemic Sclerosis: A Double-Blind Randomized Clinical Trial

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2011English

A Head-To-Head Comparison of Aripiprazole and Risperidone for Safety and Treating Autistic Disorders, a Randomized Double Blind Clinical Trial

Child Psychiatry and Human Development
DevelopmentalMental HealthChild HealthEducational PsychologyPerinatologyPsychiatryPediatrics
2013English

EHMTI-0031. Efficacy and Safety of Venlafaxine for the Treatment of Chronic Migraine: A Randomized, Double-Blind, Controlled Trial

Journal of Headache and Pain
MedicineNeurologyAnesthesiologyPain Medicine
2014English

IQP-GC-101 Reduces Body Weight and Body Fat Mass: A Randomized, Double-Blind, Placebo-Controlled Study

Phytotherapy Research
Pharmacology
2014English

Double-Blind, Randomized, Controlled Clinical Trial of Norfloxacin for Cholera.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1990English

Safety and Radiosensitizing Efficacy of Sanazole (AK 2123) in Oropharyngeal Cancers: Randomized Controlled Double Blind Clinical Trial

Indian Journal of Cancer
Oncology
2006English

Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial

Pediatrics
Child HealthPediatricsPerinatology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy